• SPX
  • $5,712.69
  • -0.28 %
  • -$16.11
  • DJI
  • $41,794.60
  • -0.61 %
  • -$257.59
  • N225
  • $38,573.16
  • 1.37 %
  • $519.56
  • FTSE
  • $8,184.24
  • 0.09 %
  • $7.09
  • IXIC
  • $18,179.98
  • -0.33 %
  • -$59.93
CNS Pharmaceuticals, Inc. (CNSP) Insider Traders

CNS Pharmaceuticals, Inc. (CNSP) Insider Traders

NASDAQ Currency in USD Disclaimer

Stock Price

$0.10

-$0.01

(-10.38%)

Day's range
$0.1
Day's range
$0.11
  • NUMBER OF INSIDER BUYING

    (Last 12 Months)

    4
  • NUMBER OF INSIDER SELLING

    (Last 12 Months)

    0
  • AMOUNT OF INSIDERS BUYING

    (Last 12 Months)

    $89,999
  • AMOUNT OF INSIDERS SELLING

    (Last 12 Months)

    $0

CNS Pharmaceuticals, Inc. Insider Transactions

CNS Pharmaceuticals, Inc. Insider Trades History

Insider Name Buy/Sell Shares Bought/Sold
@ Price
Total Transaction Shares Held
After Transaction
Transaction Date Filing Date Details
Gumulka Jerzy

Director

Buy 33,333 @ $0.30 $10,000 43,006 02/01/2024 02/06/2024
Buy 33,333 @ $0.30 $10,000 33,458 02/01/2024 02/06/2024
Buy 66,666 @ $0.30 $20,000 103,438 02/01/2024 02/06/2024
Buy 166,666 @ $0.30 $50,000 215,676 02/01/2024 02/06/2024
Buy 27,000 @ $1.27 $34,177 36,772 08/22/2023 08/23/2023
Buy 2,750 @ $1.80 $4,945 49,010 08/16/2023 08/16/2023
Gumulka Jerzy

Director

Buy 2,500 @ $1.70 $4,250 9,673 04/19/2023 04/21/2023
Buy 3,100 @ $3.20 $9,920 9,251 04/17/2023 04/18/2023
Buy 15,000 @ $0.69 $10,409 45,010 04/12/2023 04/14/2023
Gumulka Jerzy

Director

Buy 7,173 @ $0.74 $5,308 7,173 04/10/2023 04/17/2023
Priebe Waldemar

10 percent owner

Sell 10,000 @ $1.04 $10,400 156,807 03/28/2023 08/01/2023
Priebe Waldemar

10 percent owner

Sell 5,000 @ $1.09 $5,450 166,807 03/27/2023 08/01/2023
Priebe Waldemar

10 percent owner

Sell 5,000 @ $1.08 $5,400 171,807 03/24/2023 08/01/2023
Priebe Waldemar

10 percent owner

Sell 10,000 @ $1.08 $10,800 176,807 03/23/2023 08/01/2023
Priebe Waldemar

10 percent owner

Sell 5,000 @ $1.08 $5,400 186,807 03/22/2023 08/01/2023
Priebe Waldemar

10 percent owner

Sell 5,000 @ $1.10 $5,500 191,807 03/21/2023 08/01/2023
Priebe Waldemar

10 percent owner

Sell 5,000 @ $1.08 $5,400 196,807 03/20/2023 08/01/2023
Priebe Waldemar

10 percent owner

Sell 5,000 @ $1.13 $5,650 201,807 03/17/2023 08/01/2023
Priebe Waldemar

10 percent owner

Sell 5,000 @ $1.24 $6,200 206,807 03/16/2023 08/01/2023
Priebe Waldemar

10 percent owner

Sell 5,000 @ $1.22 $6,100 211,807 03/15/2023 08/01/2023

CNS Pharmaceuticals, Inc. Frequently Asked Questions

  • Who is on CNS Pharmaceuticals, Inc.'s Insider Roster?

    The list of insiders at CNS Pharmaceuticals, Inc. includes Climaco John M, Downs Christopher, Evans Carl Anthony, Gumulka Jerzy.

  • How much insider buying is happening at CNS Pharmaceuticals, Inc.?

    Insiders have purchased a total of 299,998 CNS Pharmaceuticals, Inc. shares in the last 12 months for a total of 89,999 sold.

  • Which CNS Pharmaceuticals, Inc. insiders have been buying company stock?

    The following insiders have purchased CNS Pharmaceuticals, Inc. shares in the last 12 months: Climaco John M ($50,000), Downs Christopher ($20,000), Evans Carl Anthony ($10,000), Gumulka Jerzy ($10,000),

×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.